Skip to main content

IRB Committee 1

IRB Committee 1 is responsible for the full review of human subjects research protocols submitted by faculty/staff for:

  • Health & Human Performance (HHP) Department of CLASS
  • College of Education
  • College of Medicine
  • College of Natural Sciences & Mathematics
  • College of Nursing
  • College of Optometry
  • College of Pharmacy
  • College of Technology
  • Cullen College of Engineering
All FDA-regulated research is also reviewed by IRB 1, regardless of college.

Full Committee

Submission Deadlines IRB 1 Meeting Dates
Friday, August 6, 2021 Friday, August 20, 2021
Friday, September 3, 2021 Friday, September 17, 2021
Friday, October 1, 2021 Friday, October 15, 2021
Friday, November 5, 2021 Friday, November 19, 2021
Wednesday, November 24, 2021 Friday, December 10, 2021
Friday, January 7, 2022 Friday, January 21, 2022
Friday, February 4, 2022 Friday, February 18, 2022
Friday, March 4, 2022 Friday, March 18, 2022
Friday, April 1, 2022 Friday, April 15, 2022
Friday, May 6, 2022 Friday, May 20, 2022
Friday, June 3, 2022 Friday, June 17, 2022
Friday, July 1, 2022 Friday, July 15, 2022
Friday, August 5, 2022 Friday, August 19, 2022

*Dates are subject to change without notice if circumstances require rescheduling.

Expedited Review 

Protocols falling under an expedited category and involving no more than minimal risk, as well as minor changes in approved full board protocols, may be reviewed under an expedited process. The Chair of IRB 1 either reviews or delegates the review to one or more experienced IRB members, who review the protocol under applicable regulations and either approve or require modifications to the protocol prior to approval. An expedited reviewer may not disapprove a protocol, but may forward to the fully convened committee for further determination if warranted. Expedited submissions are considered on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.  

Exempt Status

Protocols falling under an exempt category defined under the federal regulations require administrative review by the IRB office to ensure that basic ethical principles, such as confidentiality of data and obtaining informed consent where applicable, are addressed. Applications for exempt protocols are reviewed by IRB staff on a rolling basis, thus turnaround time for these submissions is expected to be quicker than for protocols undergoing full board review.